• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Otsuka`s guadecitabine flunks 2 more late-phase cancer trials

    FIERCE BIOTECH

    Astex trials of guadecitabine for leukaemia fail to meet primary end point

    CLINICALTRIALSAENA

    Otsuka scores PhIII win for another Astex drug; GSK expands Nucala use in asthma

    ENDPTS

    Otsuka’s $886M-plus drug just flopped in its first crucial PhIII trial for AML

    ENDPTS

    Astex Pharms, Otsuka Announce Results of Ph 3 ASTRAL-1 Study of Guadecitabine

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.